Andere talen Merck & Co., Inc.

Aandelen

MRK

US58933Y1055

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 08-07-2025			Voorbeurs 14:49:59
81,37 ^USD	+0,58%		81,86	+0,60%

14:04	Merck betaalt 10 miljard dollar voor Verona in poging om verder te diversifiëren dan Keytruda	RE
14:04	Merck legt $10 miljard neer voor overname van Verona in poging om afhankelijkheid van Keytruda te verminderen	RE

Andere talen

Merck: confirms acquisition of Verona Pharma	14:23
Merck : met la main sur Verona Pharma et son produit Ohtuvayre	14:23
MÄRKTE USA/Börse gut behauptet erwartet - Zurückhaltung vor Fed-Protokoll	14:21
Merck spends $10 billion for Verona, gaining access to its COPD medication	14:21
L'américain Merck annonce le rachat de la biotech Verona	14:09
USA-Les valeurs à suivre à Wall Street (actualisé)	14:05
Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda	14:04
Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda	14:04
US-Pharmakonzern Merck will britische Verona Pharma kaufen	13:40
Stocks Rise Pre-Bell as Investors Digest Trump's Latest Tariff Announcements; Fed Meeting Minutes on Deck	13:36
Merck to Buy Verona Pharma in $10 Billion Deal -- Update	13:19
Merck annonce le rachat de la biotech Verona pour 10 milliards de dollars	13:12
Merck to Buy Verona Pharma in $10 Billion Deal	13:06
Merck & Co will Biotechfirma Verona Pharma für 10 Milliarden US-Dollar kaufen	13:05
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	13:01
Merck to Buy Verona Pharma in $10 Billion Deal	12:55
Merck to Acquire Verona Pharma in $10 Billion Deal	12:52
Verona Pharma Shares Pop Premarket on Report of Merck Takeover	12:45
Merck to acquire Verona Pharma for $10 billion	12:34
Merck to acquire Verona Pharma for $10 billion	12:33
Merck Nears $10 Billion Takeover of Verona Pharma, FT Says, Citing Sources	12:32
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade	12:31
Merck Close to Acquiring Verona Pharma	12:06
Deals of the day-Mergers and acquisitions	11:48
Merck: could buy Verona Pharma for $10bn	10:20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Merck & Co., Inc.

Aandelen

MRK

US58933Y1055

Farmaceutische producten

Andere talen

Filters